Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study.
Levy
Yair
Y
Sheba Medical Center, Tel Hashomer, Israel.
Amital
Howard
H
Langevitz
Pnina
P
Nacci
Francesca
F
Righi
Anna
A
Conforti
Letizia
L
Generini
Sergio
S
Matucci Cerinic
Marco
M
Shoenfeld
Yehuda
Y
D000328:Adult; D000368:Aged; D005260:Female; D005355:Fibrosis; D006801:Humans; D016756:Immunoglobulins, Intravenous; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000473:pathology*; D012867:Skin / Q000473:pathology*; D013997:Time Factors; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous